Sertraline or placebo in chronic breathlessness? Lessons from placebo research
- PMID: 30655452
- DOI: 10.1183/13993003.02316-2018
Sertraline or placebo in chronic breathlessness? Lessons from placebo research
Conflict of interest statement
Conflict of interest: D.C. Currow is an unpaid member of an advisory board for Helsinn Pharmaceuticals, is a consultant to Specialised Therapeutics and Mayne Pharma and received intellectual property payments from Mayne Pharma. Conflict of interest: M. Agar has nothing to disclose. Conflict of interest: M. Ekström has nothing to disclose.
Comment on
-
Sertraline in symptomatic chronic breathlessness: a double blind, randomised trial.Eur Respir J. 2019 Jan 17;53(1):1801270. doi: 10.1183/13993003.01270-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30361250 Clinical Trial.
-
Sertraline or placebo in chronic breathlessness? Lessons from placebo research.Eur Respir J. 2019 Jan 17;53(1):1802225. doi: 10.1183/13993003.02225-2018. Print 2019 Jan. Eur Respir J. 2019. PMID: 30655451 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources